This Project Grant award from the National Institute on Drug Abuse (CFDA 93.279 - Drug Use and Addiction Research Programs) to Addinex Technologies, Inc. aims to integrate and assess a closed-loop medication management system focused on controlling and monitoring opioid usage for ambulatory patients with extremity fractures being discharged from the emergency department.
The key product being developed is the Addinex system, which packages opioid medications in mechanical dispensers that require a unique passcode provided through a smartphone app to access each dose. This system is designed to limit individual dose access, promote proper medication disposal, and enable remote monitoring of patient opioid usage. The $295,906 award will fund the adaptation of the Addinex system to hospital pharmacy workflows, streamline onboarding procedures, and conduct a clinical trial with 100 patients to evaluate the system's effectiveness in controlling opioid usage, promoting proper disposal, and supporting patient well-being. The project aims to demonstrate the Addinex system's ability to successfully operate within a hospital environment and provide a comprehensive opioid management solution.
Generated 1/28/25, 8:23 AM